News

Home>News>

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+11:00February 13th, 2019|

Eradicate Cancer 2020 – Next frontiers in immunotherapy

Melbourne Convention and Exhibition Centre, 25-27 March 2020

“Success Breeds Success”

The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success.

It […]

2019-07-22T04:00:07+10:00January 29th, 2019|

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs

UNIVERSITY OF CALIFORNIA – SAN DIEGO

Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]

2018-12-20T02:44:33+11:00December 20th, 2018|

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

Sydney Morning Herald (By Esther Han)

19 December 2018 — 12:00am

https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html

A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.

Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]

2018-12-20T00:05:33+11:00December 19th, 2018|

Meet our newest recruit

Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal.

I’ve always had an insatiable curiosity and a passion for big-picture ideas.  Growing up both my mother and grandmother had cancer.  After such an early confrontation with the absence of health — something most of us take for granted […]

2018-12-18T02:01:36+11:00December 18th, 2018|

Come Hell Or High Water

Cartherics Communications Adviser Leigh Dayton reveals the lengths Cartherics co-founder and immunologist Richard Boyd will go to for a good conversation.

It was a dark and stormy night.  OK, that’s a slight exaggeration, but it was the day Richard Boyd was flying from Melbourne to Sydney […]

2018-12-04T04:02:22+11:00December 4th, 2018|

The Beautiful Cure’ Reveals The ‘Profound’ Power Of The Immune System

An interview with UK immunologist Daniel Davis on national Public Radio’s “Fresh Air” is a good discussion about his new book for a general audience.

https://www.npr.org/2018/11/26/670793745/the-beautiful-cure-reveals-the-profound-power-of-the-immune-system

November 26, 20181:51 PM ET Heard on Fresh Air

Immunologist Daniel Davis says scientists are harnessing the power of the immune system to create new medications […]

2018-11-29T03:48:15+11:00November 29th, 2018|

Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’

WHAT PISSES ME OFF

When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos leaves risk-averse Australia in the innovation dust.

I’VE WORKED my whole career in the biotechnology/pharmaceutical industry.  Sometimes in business development, sometimes in drug development, sometimes in project management, sometimes in […]

2018-12-10T01:04:58+11:00November 22nd, 2018|
Go to Top